Literature DB >> 1850042

Formation and selection of intergenogroup reassortants during cell culture adaptation of rotaviruses from dually infected subjects.

R L Ward1, O Nakagomi, D R Knowlton, M M McNeal, T Nakagomi, N Huda, J D Clemens, D A Sack.   

Abstract

A previous study showed that intergenogroup reassortants of human rotaviruses can persist in nature (R.L. Ward, O. Nakagomi, D.R. Knowlton, M.M. McNeal, T. Nakagomi, J.D. Clemens, D.A. Sack, and G.M. Schiff, J. Virol. 64:3219-3225, 1990), but the mechanisms involved in their formation and selection had not been determined. In this study it was shown that, during cell culture adaptation of rotaviruses belonging to different genogroups from stools of dually infected subjects, intergenogroup reassortants were formed and selected, presumably mimicking the processes that occur in nature.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1850042      PMCID： PMC240631     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  12 in total

1.  Evidence for natural reassortants of human rotaviruses belonging to different genogroups.

Authors:  R L Ward; O Nakagomi; D R Knowlton; M M McNeal; T Nakagomi; J D Clemens; D A Sack; G M Schiff
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

Review 2.  Rotavirus gene structure and function.

Authors:  M K Estes; J Cohen
Journal:  Microbiol Rev       Date:  1989-12

3.  Reassortant formation and selection following coinfection of cultured cells with subgroup 2 human rotaviruses.

Authors:  R L Ward; D R Knowlton; P F Hurst
Journal:  J Gen Virol       Date:  1988-01       Impact factor: 3.891

4.  Efficiency of human rotavirus propagation in cell culture.

Authors:  R L Ward; D R Knowlton; M J Pierce
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

5.  Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2.

Authors:  A R Kalica; H B Greenberg; R T Espejo; J Flores; R G Wyatt; A Z Kapikian; R M Chanock
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

6.  Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus.

Authors:  H B Greenberg; J Flores; A R Kalica; R G Wyatt; R Jones
Journal:  J Gen Virol       Date:  1983-02       Impact factor: 3.891

7.  Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity.

Authors:  Y Hoshino; M M Sereno; K Midthun; J Flores; A Z Kapikian; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  Identification of the two rotavirus genes determining neutralization specificities.

Authors:  P A Offit; G Blavat
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

9.  RNA-RNA hybridization identifies a human rotavirus that is genetically related to feline rotavirus.

Authors:  T Nakagomi; O Nakagomi
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

10.  Genotypic selection following coinfection of cultured cells with subgroup 1 and subgroup 2 human rotaviruses.

Authors:  R L Ward; D R Knowlton
Journal:  J Gen Virol       Date:  1989-07       Impact factor: 3.891
View more
  3 in total

1.  Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotype.

Authors:  Monica M McNeal; Karol Sestak; Anthony H-C Choi; Mitali Basu; Michael J Cole; Pyone P Aye; Rudolf P Bohm; Richard L Ward
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Hemagglutinin activity of two distinct genogroups of feline and canine rotavirus strains.

Authors:  M Mochizuki; O Nakagomi; S Shibata
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 3.  Human Rotavirus Reverse Genetics Systems to Study Viral Replication and Pathogenesis.

Authors:  Satoshi Komoto; Saori Fukuda; Takayuki Murata; Koki Taniguchi
Journal:  Viruses       Date:  2021-09-08       Impact factor: 5.048
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.